By Lauraann Wood ( December 22, 2017, 12:40 PM EST) -- An Illinois federal judge on Friday wiped out a $150 million verdict and ordered a new trial over allegations that AbbVie Inc. fraudulently misrepresented what its testosterone replacement drug AndroGel could treat, overturning the result of the first bellwether trial in multidistrict litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.